Belfast health-technology firm Neurovalens has secured new funding to hold out scientific trials into the usage of its know-how for the remedy of tension and post-traumatic stress dysfunction (PTSD.
The corporate, which specialises in non-invasive neuro-technology to deal with well being challenges, together with metabolic illnesses equivalent to Kind 2 diabetes and weight problems, secured a grant of £225,000 (€264,000) from Make investments Northern Eire to assist the event of the know-how.
The funding will assist the corporate to undertake a sequence of scientific trials on the security and efficacy of utilizing the know-how as remedy for nervousness problems. The trials will probably be run in collaboration with Ulster College, Coleraine, and the College of California, San Diego.
The corporate has developed medical units to ship low-level electrical stimulation to deep elements of the mind and nervous system in a non-invasive means, eliminating the necessity for implanted electrodes.
“Nervousness problems are sadly the commonest psychological well being problems internationally, and within the US alone have an effect on round 20 per cent of the inhabitants,” mentioned chief govt Dr Jason McKeown.
“PTSD accounts for about eight million particular person instances. We imagine that providing a lot earlier, non-invasive intervention could possibly be actually transformative for somebody who’s fighting their psychological well being.”
Chief monetary officer Niall Quinn mentioned the first focus is to realize reimbursement standing for all its medical units throughout the US healthcare market, accelerating its FDA approval plans and transfer to the subsequent stage of commercialisation.
Final 12 months, Neurovalens raised £5.2 million from UK and Irish traders to develop current scientific trials, fund new ones and develop the know-how for use to deal with wider vary of situations.
“Neurovalens has created a buzz internationally with the introduction of non-invasive modern well being applied sciences which goal to assist customers with various well being considerations,” mentioned Dr Vicky Kell, Make investments NI’s director of innovation, analysis and growth. “The corporate first began out on our Propel Programme and since then we now have continued to assist it to develop by means of job creation, R&D and advertising actions. It’s nice to see one other NI firm recognise the worth of investing in R&D to assist competitiveness, job creation and export led development.”
Initially printed right here.